Details for Patent: 9,808,468
✉ Email this page to a colleague
Which drugs does patent 9,808,468 protect, and when does it expire?
Patent 9,808,468 protects VIVLODEX and is included in one NDA.
This patent has sixteen patent family members in sixteen countries.
Summary for Patent: 9,808,468
Title: | Formulation of meloxicam |
Abstract: | Unit dosage forms of meloxicam containing either 5 mg or 10 mg of meloxicam that provide effective pain relief and have desirable pharmacokinetic properties are described. The unit dosage forms can provide pain relief when a single unit dose is administered to a patient and useful for treating pain such as osteoarthritis pain at a relatively low systemic exposure to meloxicam. |
Inventor(s): | Bosch; H. William (Bryn Mawr, PA) |
Assignee: | iCeutica Pty Ltd. (Iluka, WA, AU) |
Application Number: | 15/595,446 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,808,468 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Dosage form; |
Drugs Protected by US Patent 9,808,468
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Iceutica Operations | VIVLODEX | meloxicam | CAPSULE;ORAL | 207233-001 | Oct 22, 2015 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | MANAGEMENT OF OSTEOARTHRITIS PAIN BY ADMINISTERING 10 MG OF MELOXICAM | ⤷ Sign Up | ||||
Iceutica Operations | VIVLODEX | meloxicam | CAPSULE;ORAL | 207233-001 | Oct 22, 2015 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | MANAGEMENT OF OSTEOARTHRITIS PAIN BY ADMINISTERING 5 MG OF MELOXICAM | ⤷ Sign Up | ||||
Iceutica Operations | VIVLODEX | meloxicam | CAPSULE;ORAL | 207233-002 | Oct 22, 2015 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | MANAGEMENT OF OSTEOARTHRITIS PAIN BY ADMINISTERING 5 MG OF MELOXICAM | ⤷ Sign Up | ||||
Iceutica Operations | VIVLODEX | meloxicam | CAPSULE;ORAL | 207233-002 | Oct 22, 2015 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | MANAGEMENT OF OSTEOARTHRITIS PAIN BY ADMINISTERING 10 MG OF MELOXICAM | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,808,468
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2015274838 | ⤷ Sign Up | |||
Brazil | 112016027435 | ⤷ Sign Up | |||
Canada | 2951383 | ⤷ Sign Up | |||
China | 107073010 | ⤷ Sign Up | |||
Eurasian Patent Organization | 201692392 | ⤷ Sign Up | |||
European Patent Office | 3151835 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |